204 related articles for article (PubMed ID: 12037728)
1. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.
Temelkova-Kurktschiev T; Siegert G; Bergmann S; Henkel E; Koehler C; Jaross W; Hanefeld M
Metabolism; 2002 Jun; 51(6):743-9. PubMed ID: 12037728
[TBL] [Abstract][Full Text] [Related]
2. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
Kahn SE; Zinman B; Haffner SM; O'Neill MC; Kravitz BG; Yu D; Freed MI; Herman WH; Holman RR; Jones NP; Lachin JM; Viberti GC;
Diabetes; 2006 Aug; 55(8):2357-64. PubMed ID: 16873701
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.
Osei K; Gaillard T; Schuster D
Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222
[TBL] [Abstract][Full Text] [Related]
4. The relation of body fat mass and distribution to markers of chronic inflammation.
Festa A; D'Agostino R; Williams K; Karter AJ; Mayer-Davis EJ; Tracy RP; Haffner SM
Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1407-15. PubMed ID: 11673759
[TBL] [Abstract][Full Text] [Related]
5. Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects.
Hanley AJ; Retnakaran R; Qi Y; Gerstein HC; Perkins B; Raboud J; Harris SB; Zinman B
J Clin Endocrinol Metab; 2009 Oct; 94(10):3824-32. PubMed ID: 19622625
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and glycemic tolerance status in pregnancy: the role of maternal adiposity.
Özyer Ş; Engin-Üstün Y; Uzunlar Ö; Katar C; Danışman N
Gynecol Obstet Invest; 2014; 78(1):53-8. PubMed ID: 24903901
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes.
Temelkova-Kurktschiev T; Koehler C; Henkel E; Hanefeld M
Cardiovasc Res; 2002 Nov; 56(2):277-83. PubMed ID: 12393098
[TBL] [Abstract][Full Text] [Related]
8. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity.
Yuan G; Zhou L; Tang J; Yang Y; Gu W; Li F; Hong J; Gu Y; Li X; Ning G; Chen M
Diabetes Res Clin Pract; 2006 Jun; 72(3):244-50. PubMed ID: 16377022
[TBL] [Abstract][Full Text] [Related]
9. [White blood cell count as a predictor of glucose tolerance and insulin sensitivity. The role of inflammation in the pathogenesis of type 2 diabetes mellitus].
Fritsche A; Häring H; Stumvoll M
Dtsch Med Wochenschr; 2004 Feb; 129(6):244-8. PubMed ID: 14750050
[TBL] [Abstract][Full Text] [Related]
10. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.
Osei K; Gaillard T; Schuster D
Obes Res; 2005 Jan; 13(1):179-85. PubMed ID: 15761178
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
[TBL] [Abstract][Full Text] [Related]
12. Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes.
Osei K; Gaillard T; Kaplow J; Bullock M; Schuster D
Metabolism; 2004 Dec; 53(12):1552-7. PubMed ID: 15562399
[TBL] [Abstract][Full Text] [Related]
13. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study).
Marques-Vidal P; Bastardot F; von Känel R; Paccaud F; Preisig M; Waeber G; Vollenweider P
Clin Endocrinol (Oxf); 2013 Feb; 78(2):232-41. PubMed ID: 22409372
[TBL] [Abstract][Full Text] [Related]
14. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.
Hanefeld M; Koehler C; Fuecker K; Henkel E; Schaper F; Temelkova-Kurktschiev T;
Diabetes Care; 2003 Mar; 26(3):868-74. PubMed ID: 12610051
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity.
Lu B; Yang Y; Yang Z; Feng X; Wang X; Zhang Z; Hu R
Cardiovasc Diabetol; 2010 Dec; 9():92. PubMed ID: 21167068
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Festa A; D'Agostino R; Tracy RP; Haffner SM;
Diabetes; 2002 Apr; 51(4):1131-7. PubMed ID: 11916936
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein and gestational diabetes: the central role of maternal obesity.
Retnakaran R; Hanley AJ; Raif N; Connelly PW; Sermer M; Zinman B
J Clin Endocrinol Metab; 2003 Aug; 88(8):3507-12. PubMed ID: 12915627
[TBL] [Abstract][Full Text] [Related]
18. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.
Kopp HP; Krzyzanowska K; Möhlig M; Spranger J; Pfeiffer AF; Schernthaner G
Int J Obes (Lond); 2005 Jul; 29(7):766-71. PubMed ID: 15917853
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment by post-challenge plasma glucose, insulin response ratio, and other indices of insulin resistance and/or secretion for predicting the development of type 2 diabetes.
Tanabe N; Saito K; Yamada Y; Takasawa T; Seki N; Suzuki H
Intern Med; 2009; 48(6):401-9. PubMed ID: 19293537
[TBL] [Abstract][Full Text] [Related]
20. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
Festa A; Hanley AJ; Tracy RP; D'Agostino R; Haffner SM
Circulation; 2003 Oct; 108(15):1822-30. PubMed ID: 14517163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
